Regarding medicine options, four studies [8, 18–20] examined the effects of combination therapy comprising sitagliptin and insulin compared with insulin monotherapy on T1DM, and the other study [13] investigated vildagliptin. Here, INS is linked to type 1 diabetes mellitus.